Jonathan Baliff
Insider
First SEC filing: May 5, 2008 · Latest: May 5, 2008
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 28, 2026 | TCBIO | A | 1,092 | · | · | 1,092 Direct | · | Acquired | (price as of 2026-10-02) |
| April 22, 2026 | TCBIO | M | 1,670 | · | · | 11,265 Direct | +17.40% | Acquired | (price as of 2026-10-02) |
| April 22, 2026 | TCBIO | M | 1,670 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| July 16, 2025 | RDW | A | 43,269 | · | · | 1,044,790 Direct | +4.32% | Acquired | (price as of 2026-10-02) |
| July 16, 2025 | RDW | A | 43,269 | · | · | 43,269 Direct | · | Acquired | (price as of 2026-10-02) |
| July 11, 2025 | RDW | F | 15,501 | $16.64 | $257,937 | 1,001,521 Direct | -1.52% | Disposed | -34.6% (price as of 2026-10-02) |
| July 3, 2025 | RDW | F | 7,305 | $15.99 | $116,807 | 1,017,022 Direct | -0.71% | Disposed | -32.0% (price as of 2026-10-02) |
| July 1, 2025 | RDW | F | 4,627 | $15.31 | $70,839 | 1,024,327 Direct | -0.45% | Disposed | -28.9% (price as of 2026-10-02) |
| April 23, 2025 | TCBIO | M | 1,330 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 23, 2025 | TCBIO | M | 1,330 | · | · | 9,595 Direct | +16.09% | Acquired | (price as of 2026-10-02) |
| April 22, 2025 | TCBIO | A | 1,670 | · | · | 1,670 Direct | · | Acquired | (price as of 2026-10-02) |
| March 19, 2025 | RDW | P | 2,170 | $11.38 | $24,695 | 1,028,954 Direct | +0.21% | Acquired | -4.4% (price as of 2026-10-02) |
| July 11, 2024 | RDW | A | 119,531 | · | · | 1,026,784 Direct | +13.18% | Acquired | (price as of 2026-10-02) |
| July 11, 2024 | RDW | A | 119,531 | · | · | 119,531 Direct | · | Acquired | (price as of 2026-10-02) |
| July 3, 2024 | RDW | F | 7,305 | $6.99 | $51,062 | 907,253 Direct | -0.80% | Disposed | 55.7% (price as of 2026-10-02) |
| July 1, 2024 | RDW | F | 4,627 | $6.94 | $32,111 | 914,558 Direct | -0.50% | Disposed | 56.8% (price as of 2026-10-02) |
| April 23, 2024 | TCBIO | A | 1,330 | · | · | 1,330 Direct | · | Acquired | (price as of 2026-10-02) |
| April 18, 2024 | TCBIO | M | 1,631 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 18, 2024 | TCBIO | M | 1,631 | · | · | 8,265 Direct | +24.59% | Acquired | (price as of 2026-10-02) |
| Nov. 17, 2023 | RDW | P | 2,500 | $2.44 | $6,100 | 919,185 Direct | +0.27% | Acquired | 345.9% (price as of 2026-10-02) |
| July 3, 2023 | RDW | F | 6,280 | $2.63 | $16,516 | 826,685 Direct | -0.75% | Disposed | 313.7% (price as of 2026-10-02) |
| July 3, 2023 | RDW | A | 90,000 | · | · | 916,685 Direct | +10.89% | Acquired | (price as of 2026-10-02) |
| July 3, 2023 | RDW | A | 90,000 | · | · | 90,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 19, 2023 | TCBIO | M | 1,377 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 19, 2023 | TCBIO | M | 1,377 | · | · | 6,634 Direct | +26.19% | Acquired | (price as of 2026-10-02) |
| April 18, 2023 | TCBIO | A | 1,631 | · | · | 1,631 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 15, 2022 | RDW | P | 500 | $2.02 | $1,010 | 821,465 Direct | +0.06% | Acquired | 438.6% (price as of 2026-10-02) |
| Dec. 15, 2022 | RDW | P | 1,114 | $2.02 | $2,250 | 822,579 Direct | +0.14% | Acquired | 438.6% (price as of 2026-10-02) |
| Dec. 15, 2022 | RDW | P | 1,000 | $2.03 | $2,030 | 823,579 Direct | +0.12% | Acquired | 436.0% (price as of 2026-10-02) |
| Dec. 15, 2022 | RDW | P | 1,200 | $2.04 | $2,448 | 824,779 Direct | +0.15% | Acquired | 433.3% (price as of 2026-10-02) |
| Dec. 15, 2022 | RDW | P | 8,186 | $2.05 | $16,781 | 832,965 Direct | +0.99% | Acquired | 430.7% (price as of 2026-10-02) |
| Nov. 1, 2022 | RDW | F | 3,712 | $2.69 | $9,985 | 820,965 Direct | -0.45% | Disposed | 304.5% (price as of 2026-10-02) |
| July 1, 2022 | RDW | A | 57,000 | · | · | 824,677 Direct | +7.42% | Acquired | (price as of 2026-10-02) |
| July 1, 2022 | RDW | A | 114,000 | · | · | 114,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 3, 2022 | RDW | J | 750,177 | · | · | 767,677 Direct | +4286.73% | Acquired | (price as of 2026-10-02) |
| June 3, 2022 | RDW | J | 370,690 | · | · | 370,690 Direct | · | Acquired | (price as of 2026-10-02) |
| June 1, 2022 | RDW | D | 32,895 | · | · | 17,500 Direct | -65.27% | Disposed | (price as of 2026-10-02) |
| May 26, 2022 | RDW | A | 32,895 | · | · | 50,395 Direct | +187.97% | Acquired | (price as of 2026-10-02) |
| April 19, 2022 | TCBIO | A | 1,377 | · | · | 6,634 Direct | +26.19% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2021 | RDW | A | 12,500 | · | · | 17,500 Direct | +250.00% | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2021 | RDW | P | 5,000 | $10.00 | $50,000 | 5,000 Direct | · | Acquired | 8.8% (price as of 2026-10-02) |
| May 27, 2021 | TCBIO | S | 976 | $69.16 | $67,500 | 5,257 Direct | -15.66% | Disposed | -72.7% (price as of 2026-10-02) |
| April 20, 2021 | TCBIO | A | 1,015 | · | · | 6,233 Direct | +19.45% | Acquired | (price as of 2026-10-02) |
| June 29, 2020 | TCBIO | A | 2,242 | · | · | 5,218 Direct | +75.34% | Acquired | (price as of 2026-10-02) |
| April 16, 2019 | TCBIO | A | 1,107 | · | · | 2,976 Direct | +59.23% | Acquired | (price as of 2026-10-02) |
| April 17, 2018 | TCBIO | A | 611 | · | · | 1,806 Direct | +51.13% | Acquired | (price as of 2026-10-02) |
| July 26, 2017 | TCBIO | P | 25 | $81.55 | $2,039 | 1,195 Direct | +2.14% | Acquired | -76.8% (price as of 2026-10-02) |
| July 18, 2017 | TCBIO | A | 641 | · | · | 1,170 Direct | +121.17% | Acquired | (price as of 2026-10-02) |
| July 18, 2017 | TCBIO | A | 529 | · | · | 529 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2010 | NRG | A | 8,700 | · | · | 8,700 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2010 | NRG | A | 18,800 | · | · | 18,800 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2010 | NRG | A | 8,400 | · | · | 23,007 Direct | +57.51% | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2009 | NRG | A | 16,000 | · | · | 16,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2009 | NRG | A | 33,300 | · | · | 33,300 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2009 | NRG | A | 4,100 | · | · | 14,558 Direct | +39.20% | Acquired | (price as of 2026-10-02) |
| Sept. 9, 2008 | NRG | P | 1,000 | $30.99 | $30,990 | 9,500 Direct | +11.76% | Acquired | 207.3% (price as of 2026-10-02) |
| Sept. 9, 2008 | NRG | P | 1,000 | $31.77 | $31,770 | 8,500 Direct | +13.33% | Acquired | 199.7% (price as of 2026-10-02) |
| Sept. 9, 2008 | NRG | P | 3,500 | $32.20 | $112,700 | 7,500 Direct | +87.50% | Acquired | 195.7% (price as of 2026-10-02) |
| May 1, 2008 | NRG | A | 15,400 | · | · | 15,400 Direct | · | Acquired | (price as of 2026-10-02) |
| May 1, 2008 | NRG | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 1, 2008 | NRG | A | 4,000 | · | · | 4,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 28, 2026 | TCBIO | 2026 Restricted Stock Units | Common Stock | $0.00 | · | 1,092 | Acquired |
| April 22, 2026 | TCBIO | 2025 Restricted Stock Units | Common Stock | $0.00 | · | 1,670 | Disposed |
| July 16, 2025 | RDW | Performance-Based Restricted Stock Units (2025) | Common Stock, par value $0.0001 per share | · | Dec. 31, 2027 | 43,269 | Acquired |
| April 23, 2025 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | · | 1,330 | Disposed |
| April 22, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock | $0.00 | · | 1,670 | Acquired |
| July 11, 2024 | RDW | Performance-Based Restricted Stock Units (2024) | Common Stock, par value $0.0001 per share | · | Dec. 31, 2026 | 119,531 | Acquired |
| April 23, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | · | 1,330 | Acquired |
| April 18, 2024 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 1,631 | Disposed |
| July 3, 2023 | RDW | Performance-Based Restricted Stock Units | Common Stock, par value $0.0001 per share | · | Dec. 31, 2025 | 90,000 | Acquired |
| April 19, 2023 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 1,377 | Disposed |
| April 18, 2023 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 1,631 | Acquired |
| July 1, 2022 | RDW | Stock Option (Right to Buy) | Common Stock | $3.13 | July 1, 2032 | 114,000 | Acquired |
| June 3, 2022 | RDW | Warrants to purchase Common Stock | Common Stock | $11.50 | · | 370,690 | Acquired |
| Jan. 4, 2010 | NRG | Performance Units | Common Stock, par value $.01 per share | · | Jan. 4, 2013 | 8,700 | Acquired |
| Jan. 4, 2010 | NRG | Non-Qualified Stock Options | Common Stock, par value $.01 per share | $23.87 | Jan. 4, 2020 | 18,800 | Acquired |
| Jan. 2, 2009 | NRG | Performance Units | Common Stock, par value $.01 per share | · | Jan. 2, 2012 | 16,000 | Acquired |
| Jan. 2, 2009 | NRG | Non-Qualified Stock Options | Common Stock, par value $.01 per share | $23.64 | Jan. 2, 2015 | 33,300 | Acquired |
| May 1, 2008 | NRG | Performance Units | Common Stock, par value $.01 per share | · | May 1, 2011 | 15,400 | Acquired |
| May 1, 2008 | NRG | Non-Qualified Stock Options | Common Stock, par value $.01 per share | $42.67 | May 1, 2014 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 5, 2008 | NRG | No securities beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $444,615 | · | $1,883,067 | · | $110,042 | · | $855,832 | $3,293,556 |
| 2024 | $417,308 | · | $2,403,768 | · | $209,697 | · | $24,060 | $3,054,833 |
| 2023 | $400,000 | · | $520,200 | · | $386,587 | · | $36,755 | $1,343,542 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.